Egalet ltd. – product pipeline review – 2012


Published on announce The Latest report-Egalet Ltd. – Product Pipeline Review – 2012

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Egalet ltd. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Egalet Ltd. – Product Pipeline Review – 2012 link of Global Markets Direct Market Direct’s pharmaceuticals report, “Egalet Ltd. - Product PipelineReview - 2012” provides data on the Egalet Ltd.’s research and development focus.The report includes information on current developmental pipeline, complete withlatest updates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Egalet Ltd.’s corporate website, SEC filings, investorpresentations and featured press releases, both from Egalet Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.Scope- Egalet Ltd. - Brief Egalet Ltd. overview including business description, keyinformation and facts, and its locations and subsidiaries.- Review of current pipeline of Egalet Ltd. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:
  2. 2. List of Tables 4List of Figures 4Egalet Ltd. Snapshot 5Egalet Ltd. Overview 5Key Information 5Key Facts 5Egalet Ltd. – Research and Development Overview 6Key Therapeutic Areas 6Egalet Ltd. – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Egalet Ltd. – Pipeline Products Glance 10Egalet Ltd. Clinical Stage Pipeline Products 10Phase II Products/Combination Treatment Modalities 10Phase I Products/Combination Treatment Modalities 11Egalet Ltd. – Early Stage Pipeline Products 12Pre-Clinical Products/Combination Treatment Modalities 12Egalet Ltd. – Drug Profiles 13EG-P066 Morphine ER 13Product Description 13Mechanism of Action 13R&D Progress 13EG-P113 Hydrocodone ER 14Product Description 14Mechanism of Action 14R&D Progress 14EG-P114 Oxycodone ER 15Product Description 15Mechanism of Action 15R&D Progress 15EG-P118 Hydromorphone ER 16Product Description 16Mechanism of Action 16R&D Progress 16EG-P119 17Product Description 17
  3. 3. Mechanism of Action 17R&D Progress 17EG-P121 Hydrocodone/APAP IR 18Product Description 18Mechanism of Action 18R&D Progress 18List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1Cellceutix Pharmaceuticals, Inc. – Product Pipeline Review – 2012Ceregene, Inc. – Product Pipeline Review – 2012Curacyte AG – Product Pipeline Review – 2012DEKK-TEC, Inc. – Product Pipeline Review – 2012Egalet Ltd. – Product Pipeline Review – 2012Fresenius Biotech GmbH – Product Pipeline Review – 2012Evolva SA – Product Pipeline Review – 2012Glycotope GmbH – Product Pipeline Review – 2012
  4. 4. Hawthorn Pharmaceuticals, Inc. – Product Pipeline Review – 2012Helsinn Healthcare S.A. – Product Pipeline Review – 2012Hygeia Therapeutics, Inc. – Product Pipeline Review – 2012IkerChem S.L. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: